MDxHealth SA Files 6-K, Incorporates Exhibit 3.1
Ticker: MDXH · Form: 6-K · Filed: Oct 29, 2024 · CIK: 1872529
| Field | Detail |
|---|---|
| Company | Mdxhealth SA (MDXH) |
| Form Type | 6-K |
| Filed Date | Oct 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $40,000,000, $4.4 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration
TL;DR
MDxHealth SA filed a 6-K, incorporating an exhibit into its F-3 registration. Standard procedure.
AI Summary
MDxHealth SA filed a Form 6-K on October 29, 2024, to incorporate by reference Exhibit 3.1 into its existing Form F-3 registration statement (Registration Statement No. 333-268885). This filing relates to the month of October 2024 and indicates that MDxHealth SA is a foreign private issuer filing under the 1934 Act.
Why It Matters
This filing is a routine update that incorporates a document into an existing registration statement, which is often a precursor to or part of ongoing capital raising or reporting activities.
Risk Assessment
Risk Level: low — This is a routine administrative filing that incorporates an exhibit into an existing registration statement, with no new material financial or operational information disclosed.
Key Players & Entities
- MDxHealth SA (company) — Registrant
- 333-268885 (dollar_amount) — Form F-3 Registration Statement Number
- October 2024 (date) — Reporting period
- 20241029 (date) — Filing date
FAQ
What type of filing is MDxHealth SA submitting?
MDxHealth SA is submitting a Form 6-K, which is a Report of Foreign Private Issuer.
What is the purpose of this Form 6-K filing?
The purpose is to incorporate by reference Exhibit 3.1 into the Company's existing registration statement on Form F-3 (Registration Statement No. 333-268885).
What is the reporting period for this Form 6-K?
The reporting period is for the month of October 2024.
Is MDxHealth SA required to file annual reports on Form 20-F or 40-F?
Yes, MDxHealth SA indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address of MDxHealth SA?
The principal executive office is located at CAP Business Center, Zone Industrielle des Hauts-Sarts, 4040 Herstal, Belgium.
Filing Stats: 490 words · 2 min read · ~2 pages · Grade level 13.8 · Accepted 2024-10-29 16:05:24
Key Financial Figures
- $40,000,000 — , 2024, the Company raised an amount of $40,000,000 in gross proceeds through the issuance
- $4.4 million — Overallotment Shares was approximately $4.4 million. The closing of the offering of the Ove
Filing Documents
- ea0219057-6k_mdxhealth.htm (6-K) — 13KB
- ea021905701ex3-1_mdxhealth.htm (EX-3.1) — 179KB
- 0001213900-24-091717.txt ( ) — 193KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MDXHEALTH SA Date: October 29, 2024 By: /s/ Michael McGarrity Name: Michael McGarrity Title: Chief Executive Officer 2